{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:58:19Z","timestamp":1793383099898,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["No.5\/4\/7-5\/14\/NCD-II"],"award-info":[{"award-number":["No.5\/4\/7-5\/14\/NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PGIMER-Intramural grant","award":["01"],"award-info":[{"award-number":["01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00467-020-04798-8","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T10:04:00Z","timestamp":1603793040000},"page":"1217-1226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Primary membranous nephropathy in children and adolescents: a single-centre report from South Asia"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1273-9107","authenticated-orcid":false,"given":"Raja","family":"Ramachandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karalanglin","family":"Tiewsoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritambhra","family":"Nada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harbir Singh","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"4798_CR1","doi-asserted-by":"publisher","unstructured":"Safar-Boueri L, Piya A, Beck LH Jr, Ayalon R (2019) Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-019-04425-1","DOI":"10.1007\/s00467-019-04425-1"},{"key":"4798_CR2","doi-asserted-by":"crossref","unstructured":"(1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. Kidney Int 13:159\u2013165","DOI":"10.1038\/ki.1978.23"},{"key":"4798_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00005792-197905000-00002","volume":"58","author":"C Kleinknecht","year":"1979","unstructured":"Kleinknecht C, Levy M, Gagnadoux MF, Habib R (1979) Membranous glomerulonephritis with extra-renal disorders in children. Medicine 58:219\u2013228","journal-title":"Medicine"},{"key":"4798_CR4","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00467-006-0246-8","volume":"21","author":"BH Lee","year":"2006","unstructured":"Lee BH, Cho HY, Kang HG, Ha IS, Cheong HI, Moon KC, Lim IS, Choi Y (2006) Idiopathic membranous nephropathy in children. Pediatr Nephrol 21:1707\u20131715","journal-title":"Pediatr Nephrol"},{"key":"4798_CR5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas NM, Beck LH Jr, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, Dolla G, Hoxha E, Helmchen U, Dabert-Gay AS, Debayle D, Merchant M, Klein J, Salant DJ, Stahl R, Lambeau G (2014) Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371:2277\u20132287","journal-title":"N Engl J Med"},{"key":"4798_CR6","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1056\/NEJMoa1013792","volume":"364","author":"H Debiec","year":"2011","unstructured":"Debiec H, Lefeu F, Kemper MJ, Niaudet P, Desch\u00eanes G, Remuzzi G, Ulinski T, Ronco P (2011) Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med 364:2101\u20132110","journal-title":"N Engl J Med"},{"key":"4798_CR7","doi-asserted-by":"publisher","first-page":"8803","DOI":"10.1038\/srep08803","volume":"5","author":"H Dai","year":"2015","unstructured":"Dai H, Zhang H, He Y (2015) Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis. Sci Rep 5:8803","journal-title":"Sci Rep"},{"key":"4798_CR8","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.2215\/CJN.07210810","volume":"6","author":"JM Hofstra","year":"2011","unstructured":"Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ (2011) Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6:1286\u20131291","journal-title":"Clin J Am Soc Nephrol"},{"key":"4798_CR9","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00467-013-2574-9","volume":"28","author":"LN Cossey","year":"2013","unstructured":"Cossey LN, Walker PD, Larsen CP (2013) Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr Nephrol 28:2307\u20132311","journal-title":"Pediatr Nephrol"},{"key":"4798_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.prp.2019.01.046","volume":"215","author":"D Zhang","year":"2019","unstructured":"Zhang D, Wu Y, Zhang C, Zhang W, Zou J, Jiang G (2019) Compared staining of the phospholipase A2 receptor in the glomeruli of Chinese adults and children with idiopathic membranous nephropathy. Pathol Res Pract 215:952\u2013956","journal-title":"Pathol Res Pract"},{"key":"4798_CR11","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1056\/NEJMoa012895","volume":"346","author":"H Debiec","year":"2002","unstructured":"Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Desch\u00eanes G, Ronco PM (2002) Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053\u20132060","journal-title":"N Engl J Med"},{"key":"4798_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00467-017-3817-y","volume":"33","author":"AK Dettmar","year":"2018","unstructured":"Dettmar AK, Wiech T, Kemper MJ, Soave A, Rink M, Oh J, Stahl R, Hoxha E, Pediatric MN Study Group (2018) Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents. Pediatr Nephrol 33:463\u2013472","journal-title":"Pediatr Nephrol"},{"key":"4798_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/nep.12478","volume":"20","author":"V Kumar","year":"2015","unstructured":"Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V (2015) Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Nephrology 20:572\u2013575","journal-title":"Nephrology"},{"key":"4798_CR14","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/nep.12835","volume":"22","author":"V Kumar","year":"2017","unstructured":"Kumar V, Varma AK, Nada R, Ghosh R, Suri D, Gupta A, Kumar V, Rathi M, Kohli H, Jha V, Gupta K, Ramachandran R (2017) Primary membranous nephropathy in adolescence: a prospective study. Nephrology 22:678\u2013683","journal-title":"Nephrology"},{"key":"4798_CR15","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ekir.2017.02.004","volume":"2","author":"R Ramachandran","year":"2017","unstructured":"Ramachandran R, Yadav AK, Kumar V, Siva Tez Pinnamaneni V, Nada R, Ghosh R, Kumar V, Rathi M, Kohli HS, Gupta KL, Sakhuja V, Jha V (2017) Two-year follow-up study of membranous nephropathy treated with tacrolimus and corticosteroids versus cyclical corticosteroids and cyclophosphamide. Kidney Int Rep 2:610\u2013616","journal-title":"Kidney Int Rep"},{"key":"4798_CR16","doi-asserted-by":"crossref","unstructured":"Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, MENTOR Investigators (2019) Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med 381:36\u201346","DOI":"10.1056\/NEJMoa1814427"},{"key":"4798_CR17","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/ndt\/gfu097","volume":"29","author":"R Ramachandran","year":"2014","unstructured":"Ramachandran R, Kumar V, Rathi M, Nada R, Jha V, Gupta KL, Sakhuja V, Kohli HS (2014) Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience. Nephrol Dial Transplant 29:1918\u20131924","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4798_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"DC Cattran","year":"2012","unstructured":"Cattran DC, Feehally J, Cook HT, Liu ZH, Fervenza FC, Mezzano SA, Floege J, Nachman PH, Gipson DS, Praga M, Glassock RJ, Radhakrishnan J, Hodson EM, Rovin BH, Jha V, Troyanov S, Li PKT, Wetzels JFM (2012) Kidney disease: improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2(2):139\u2013274","journal-title":"Kidney Int Suppl"},{"key":"4798_CR19","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/ndt\/gfv399","volume":"31","author":"R Ramachandran","year":"2016","unstructured":"Ramachandran R, Kumar V, Kumar A, Yadav AK, Nada R, Kumar H, Kumar V, Rathi M, Kohli HS, Gupta KL, Sakhuja V, Jha V (2016) PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in south Asians. Nephrol Dial Transplant 31:1486\u20131493","journal-title":"Nephrol Dial Transplant"},{"key":"4798_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1874303X01912010027","volume":"12","author":"Y Inaguma","year":"2019","unstructured":"Inaguma Y, Shiratori A, Nakagawa T, Kanda K, Yoshida M, Hara S, Kaito H, Nozu K, Iijima K, Yoshikawa N, Tanaka R (2019) M-type phospholipase A2 receptor staining in children with idiopathic membranous nephropathy: PLA2R staining in children with IMN. Open Urol Nephrol J 12:27\u201332","journal-title":"Open Urol Nephrol J"},{"key":"4798_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00467-016-3552-9","volume":"32","author":"S Kanda","year":"2017","unstructured":"Kanda S, Horita S, Yanagihara T, Shimizu A, Hattori M (2017) M-type phospholipase A2 receptor (PLA2R) glomerular staining in pediatric idiopathic membranous nephropathy. Pediatr Nephrol 32:713\u2013717","journal-title":"Pediatr Nephrol"},{"key":"4798_CR22","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.2215\/CJN.01460217","volume":"12","author":"J Wang","year":"2017","unstructured":"Wang J, Cui Z, Lu J, Probst C, Zhang YM, Wang X, Qu Z, Wang F, Meng LQ, Cheng XY, Liu G, Debiec H, Ronco P, Zhao MH (2017) Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy. Clin J Am Soc Nephrol 12:1642\u20131651","journal-title":"Clin J Am Soc Nephrol"},{"key":"4798_CR23","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00467-008-1005-9","volume":"24","author":"RP Valentini","year":"2009","unstructured":"Valentini RP, Mattoo TK, Kapur G, Imam A (2009) Membranous glomerulonephritis: treatment response and outcome in children. Pediatr Nephrol 24:301\u2013308","journal-title":"Pediatr Nephrol"},{"key":"4798_CR24","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.ekir.2019.09.005","volume":"4","author":"MM O\u2019Shaughnessy","year":"2019","unstructured":"O\u2019Shaughnessy MM, Troost JP, Bomback AS, Hladunewich MA, Ashoor IF, Gibson KL, Matar RB, Selewski DT, Srivastava T, Rheault MN, Al-Uzri A, Kogon AJ, Khalid M, Vento S, Sanghani NS, Gillespie BW, Gipson DS, Wang CS, Parsa A, Guay-Woodford L, Laurin LP (2019) Treatment patterns among adults and children with membranous nephropathy in the cure glomerulonephropathy network (CureGN). Kidney Int Rep 4:1725\u20131734","journal-title":"Kidney Int Rep"},{"key":"4798_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2369-8-11","volume":"8","author":"A Chen","year":"2007","unstructured":"Chen A, Frank R, Vento S, Crosby V, Chandra M, Gauthier B, Valderrama E, Trachtman H (2007) Idiopathic membranous nephropathy in pediatric patients: presentation, response to therapy, and long-term outcome. BMC Nephrol 8:11","journal-title":"BMC Nephrol"},{"key":"4798_CR26","doi-asserted-by":"publisher","first-page":"441","DOI":"10.5414\/CN107642","volume":"80","author":"R Bhimma","year":"2013","unstructured":"Bhimma R, Naicker E, Ramdial PK (2013) Mycophenolate mofetil therapy in children with idiopathic membranous nephropathy. Clin Nephrol 80:441\u2013448","journal-title":"Clin Nephrol"},{"key":"4798_CR27","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","volume":"360","author":"G Remuzzi","year":"2002","unstructured":"Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P (2002) Rituximab for idiopathic membranous nephropathy. Lancet 360:923\u2013924","journal-title":"Lancet"},{"key":"4798_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00467-010-1671-2","volume":"26","author":"B Zhu","year":"2011","unstructured":"Zhu B, Huang J (2011) Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy. Pediatr Nephrol 26:637\u2013638","journal-title":"Pediatr Nephrol"},{"key":"4798_CR29","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00467-018-3923-5","volume":"33","author":"R Malatesta-Muncher","year":"2018","unstructured":"Malatesta-Muncher R, Eldin KW, Beck LH Jr, Michael M (2018) Idiopathic membranous nephropathy in children treated with rituximab: report of two cases. Pediatr Nephrol 33:1089\u20131092","journal-title":"Pediatr Nephrol"},{"key":"4798_CR30","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1681\/ASN.2012020181","volume":"23","author":"P Ruggenenti","year":"2012","unstructured":"Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, Rambaldi A, Maras\u00e0 M, Remuzzi G (2012) Rituximab in idiopathic membranous nephropathy. J Am Soc Nephrol 23:1416\u20131425","journal-title":"J Am Soc Nephrol"},{"key":"4798_CR31","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.2215\/CJN.05080610","volume":"5","author":"FC Fervenza","year":"2010","unstructured":"Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, Nachman PH, Bergstralh EJ, Leung N, Cosio FG, Hogan MC, Dillon JJ, Hickson LJ, Li X, Cattran DC, Mayo Nephrology Collaborative Group (2010) Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 5:2188\u20132198","journal-title":"Clin J Am Soc Nephrol"},{"key":"4798_CR32","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2215\/CJN.01180307","volume":"2","author":"P Cravedi","year":"2007","unstructured":"Cravedi P, Ruggenenti P, Sghirlanzoni MC, Remuzzi G (2007) Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2:932\u2013937","journal-title":"Clin J Am Soc Nephrol"},{"key":"4798_CR33","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/ki.2015.310","volume":"88","author":"R Ramachandran","year":"2015","unstructured":"Ramachandran R, Kumar V, Nada R, Jha V (2015) Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy. Kidney Int 88:1198\u20131199","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04798-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-020-04798-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04798-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:07:10Z","timestamp":1635293230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-020-04798-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4798"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04798-8","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Ethic committee (PGI\/IEC\/2014\/241).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent for participation was taken from all the patients and parents in case of age\u2009<\u200918\u00a0years.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of participation"}},{"value":"All authors have approved the manuscript for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}